153 related articles for article (PubMed ID: 10701525)
1. Long-term follow up of progesterone receptor status in benign meningioma: a prognostic indicator of recurrence?
Fewings PE; Battersby RD; Timperley WR
J Neurosurg; 2000 Mar; 92(3):401-5. PubMed ID: 10701525
[TBL] [Abstract][Full Text] [Related]
2. Progesterone and estrogen receptors: opposing prognostic indicators in meningiomas.
Pravdenkova S; Al-Mefty O; Sawyer J; Husain M
J Neurosurg; 2006 Aug; 105(2):163-73. PubMed ID: 17219818
[TBL] [Abstract][Full Text] [Related]
3. Progesterone and estrogen receptors in meningiomas: prognostic considerations.
Hsu DW; Efird JT; Hedley-Whyte ET
J Neurosurg; 1997 Jan; 86(1):113-20. PubMed ID: 8988089
[TBL] [Abstract][Full Text] [Related]
4. [Steroid receptors and atypical histology as prognostic parameters in meningioma].
Kostron H; Daxenbichler G; Maier H
Wien Klin Wochenschr; 1990 Sep; 102(18):525-8. PubMed ID: 2264343
[TBL] [Abstract][Full Text] [Related]
5. The prognostic value of progesterone receptor status in meningiomas.
Roser F; Nakamura M; Bellinzona M; Rosahl SK; Ostertag H; Samii M
J Clin Pathol; 2004 Oct; 57(10):1033-7. PubMed ID: 15452155
[TBL] [Abstract][Full Text] [Related]
6. The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases.
Roser F; Samii M; Ostertag H; Bellinzona M
Acta Neurochir (Wien); 2004 Jan; 146(1):37-44; discussion 44. PubMed ID: 14740263
[TBL] [Abstract][Full Text] [Related]
7. Proliferation and progesterone receptor status in benign meningiomas are not age dependent.
Roser F; Nakamura M; Ritz R; Bellinzona M; Dietz K; Samii M; Tatagiba MS
Cancer; 2005 Aug; 104(3):598-601. PubMed ID: 15952201
[TBL] [Abstract][Full Text] [Related]
8. Convexity meningiomas: study of recurrence factors with special emphasis on the cleavage plane in a series of 100 consecutive patients.
Alvernia JE; Dang ND; Sindou MP
J Neurosurg; 2011 Sep; 115(3):491-8. PubMed ID: 21663413
[TBL] [Abstract][Full Text] [Related]
9. Recurrences of meningiomas: predictive value of pathological features and hormonal and growth factors.
Maiuri F; De Caro MB; Esposito F; Cappabianca P; Strazzullo V; Pettinato G; de Divitiis E
J Neurooncol; 2007 Mar; 82(1):63-8. PubMed ID: 17225937
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic features of aggressive meningioma emphasizing the role of radiotherapy in treatment.
Engenhart-Cabillic R; Farhoud A; Sure U; Heinze S; Henzel M; Mennel HD; Bertalanffy H
Strahlenther Onkol; 2006 Nov; 182(11):641-6. PubMed ID: 17072521
[TBL] [Abstract][Full Text] [Related]
11. Immunocytochemical study of progesterone receptor in human meningioma.
Perrot-Applanat M; Groyer-Picard MT; Kujas M
Acta Neurochir (Wien); 1992; 115(1-2):20-30. PubMed ID: 1595392
[TBL] [Abstract][Full Text] [Related]
12. Proliferation potential of spinal meningiomas.
Roser F; Nakamura M; Bellinzona M; Ritz R; Ostertag H; Tatagiba MS
Eur Spine J; 2006 Feb; 15(2):211-5. PubMed ID: 15926055
[TBL] [Abstract][Full Text] [Related]
13. Long-term surgical outcomes of spinal meningiomas.
Nakamura M; Tsuji O; Fujiyoshi K; Hosogane N; Watanabe K; Tsuji T; Ishii K; Toyama Y; Chiba K; Matsumoto M
Spine (Phila Pa 1976); 2012 May; 37(10):E617-23. PubMed ID: 22146282
[TBL] [Abstract][Full Text] [Related]
14. [Clinical study on the recurrence of meningiomas: correlating factors for the recurrence and therapeutic prognosis of meningiomas].
Miyagami M; Miyagi A; Kido G; Tsubokawa T
No Shinkei Geka; 1994 May; 22(5):421-8. PubMed ID: 8196827
[TBL] [Abstract][Full Text] [Related]
15. [The characteristics of the histological structure of parasagittal meningiomas and their effect on postoperative recurrence].
Korshunov AG; Timirgaz VV; Kalinina EE; Kozlov AV
Zh Vopr Neirokhir Im N N Burdenko; 1996; (4):10-5. PubMed ID: 9092245
[TBL] [Abstract][Full Text] [Related]
16. Skull base atypical meningioma: long term surgical outcome and prognostic factors.
Wang YC; Chuang CC; Wei KC; Hsu YH; Hsu PW; Lee ST; Wu CT; Tseng CK; Wang CC; Chen YL; Jung SM; Chen PY
Clin Neurol Neurosurg; 2015 Jan; 128():112-6. PubMed ID: 25486076
[TBL] [Abstract][Full Text] [Related]
17. Histopathology and MIB-1 labeling index predicted recurrence of meningiomas: a proposal of diagnostic criteria for patients with atypical meningioma.
Ho DM; Hsu CY; Ting LT; Chiang H
Cancer; 2002 Mar; 94(5):1538-47. PubMed ID: 11920512
[TBL] [Abstract][Full Text] [Related]
18. Recurrence of benign meningiomas: predictive value of proliferative index, BCL2, p53, hormonal receptors and HER2 expression.
Abdelzaher E; El-Gendi SM; Yehya A; Gowil AG
Br J Neurosurg; 2011 Dec; 25(6):707-13. PubMed ID: 20979437
[TBL] [Abstract][Full Text] [Related]
19. Clinical and histological features of multiple meningiomas compared with solitary meningiomas.
Huang H; Buhl R; Hugo HH; Mehdorn HM
Neurol Res; 2005 Apr; 27(3):324-32. PubMed ID: 15845217
[TBL] [Abstract][Full Text] [Related]
20. The impact of progesterone receptor expression on relapse in the long-term clinical course of 93 benign meningiomas.
Strik HM; Strobelt I; Pietsch-Breitfeld B; Iglesias-Rozas JR; Will B; Meyermann R
In Vivo; 2002; 16(4):265-70. PubMed ID: 12224136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
